Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02228694 · ClinicalTrials.gov registry record
The IMPROVE Study-IMPact of a Regulated ADC System
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 120
- Enrollment target
NCT02228694 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 120 participants.
The verdict
NCT02228694 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
An automated dispensing cabinet (ADC) is a computerized drug storage device or cabinet designed for hospitals. ADCs allow medications to be stored and dispensed near the point of care while controlling and tracking drug distribution.This study seeks to obtain quantitative measurements of the impact of the regulated ADC System installed in select high volume units throughout the hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-09 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02228694
The ClinicalTrials.gov registry entry for NCT02228694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02228694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02228694 about?
NCT02228694 is a clinical study titled "The IMPROVE Study-IMPact of a Regulated ADC System". An automated dispensing cabinet (ADC) is a computerized drug storage device or cabinet designed for hospitals. ADCs allow medications to be stored and dispensed near the point of care while controlling and tracking drug distribution.This study seeks to obtain quantitative measurements of the impact ...
What is the current status of trial NCT02228694?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT02228694?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.